Author

Rojo A. Ratsimandresy

GenentechORCID 0000-0002-1615-5301Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Aaron Wong· 1 shared Alexander ArlanticoiD· 1 shared Alexander R. AbbasiD· 1 shared Andréy S. ShawiD· 1 shared Cary D. AustiniD· 1 shared Christopher J. WedelesiD· 1 shared Claire L. EmsoniD· 1 shared Cynthia J. Koziol‐WhiteiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Aaron Wong

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Combined antagonism of Oncostatin M (OSM) and Interleukin 6 (IL-6) provides both anti-fibrotic and anti-inflammatory benefit in pulmonary fibrosis

Rojo A. Ratsimandresy, Emma Doran, Hart S. Dengler, Sarah Emily Headland, Christopher J. Wedeles, Riccardo Guidi, Daqi Xu, Jiatong Liu, Yongchang Shi, Jianyong Wang, Salil Uttarwar, Alexander R. Abbas, Tianhe Sun, Daryle J. DePianto, Katrina B. Morshead, , Mark S. Wilson

This study shows that blocking OSM and IL-6 reduces fibrosis and inflammation in pulmonary fibrosis by targeting their shared receptor and distinct pathways.

bioRxiv · Jan 13, 2026 · PreprintImmunology